Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on September 9, 2025

September 9, 2025

Telix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis

GlobeNewswire

September 9, 2025

Significant Breakthrough! eefit Far Infrared Technology Improves Two Major Symptoms of Alzheimer’s Disease, Bringing New Hope to Brain Health Protection

GlobeNewswire

September 9, 2025

University Hospital Foundation announces project to support Alberta dementia patients and their families

GlobeNewswire

September 9, 2025

Actuate Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

September 9, 2025

Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance

GlobeNewswire

September 9, 2025

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

GlobeNewswire

September 9, 2025

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025

GlobeNewswire

September 9, 2025

Celcuity Announces Upsized Senior Secured Term Loan Facility of $500 Million with Innovatus Capital Partners and Oxford Finance

GlobeNewswire

September 9, 2025

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

GlobeNewswire

September 9, 2025

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease

GlobeNewswire

September 9, 2025

Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection

GlobeNewswire

September 9, 2025

KFSHRC Concludes Strategic Role at C3 Davos of Healthcare New York Summit

GlobeNewswire

September 9, 2025

OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025

GlobeNewswire

September 9, 2025

Leading Health Organizations Call for Nutrition Education to Become a Core Part of Medical Training

GlobeNewswire

September 9, 2025

Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight

GlobeNewswire

September 9, 2025

Del Bigtree and ICAN Announce Senate Hearing on Science and Corruption, Featuring Groundbreaking Study and Announces Documentary, "An Inconvenient Study"

GlobeNewswire

September 9, 2025

130+ Strategies for Resilient Rural Water and Sanitation Across the United States

GlobeNewswire

September 9, 2025

Misophonia Research Fund to Host Impactful Conference on Misophonia: Bringing Together Science and Lived Experience to Create Solutions

GlobeNewswire

September 9, 2025

Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025

GlobeNewswire

September 9, 2025

Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025

GlobeNewswire